Orlistat PD Endpoint Determination during BE study [Design Issues]

posted by luvblooms  – India, 2015-03-09 07:44 (4131 d 08:07 ago) – Posting: # 14552
Views: 6,944

Done one study on orlistat.

And believe me, it is going to be a tough one!! (main problem was keeping volunteers in the facility for ~45-60 day apart from the faecal collection method). But we did that and failed ;-)

Do check this one too

Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.

Hope this will help

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
195 visitors (0 registered, 195 guests [including 19 identified bots]).
Forum time: 16:52 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5